| Product Description |
 |
FibroMalic offers a novel formulation consisting of malic acid, l-carnitine and magnesium for rejuvenating muscle energy and promoting muscle comfort.
Uses For FibroMalic
Support For Muscular Function and Comfort: Malic acid
and magnesium provide synergistic support for energy production. Malic acid serves as a substrate for energy release from the Krebs cycle (a physiological process in the body that metabolizes fats and sugars), and magnesium plays a major role in the formation of ATP, the body's energy storage molecule. In addition, malic acid has also been shown to play a role in maintaining muscle comfort. l-Carnitine is also crucial for mitochondrial production of ATP in skeletal muscle and enhances the ability of muscle to sustain energy and proper function by supporting healthy oxygenation of tissue. A recent study suggests that a combination of malic acid and magnesium nutritionally supports energy and muscle health in volunteers. Similar support was demonstrated for individuals supplementing with l-carnitine in a separate study.
|
| |
| Suggested Use
|
|
| Pure Encapsulations recommends 3–6 capsules per
day, in divided doses, with meals, or as directed by
your physician.
|
| |
| Ingredients/Supplement Facts
|
|
| Supplement Facts |
each vegetable capsule contains |
| Ingredients |
Amount |
%DV |
| malic acid |
200 mg. |
|
| magnesium (aspartate) |
40 mg. |
|
l-carnitine (free-form)
(from 344 mg.of l-carnitine fumarate) |
200 mg |
|
|
| Other
Ingredients:3 –6 capsules per day,in divided doses,with meals,or as directed
by your physician. |
|
|
| |
| Additional Information |
|
| Magnesium may interfere with potassium-sparing
diuretics. It may also reduce the absorption of some antibiotics, Warfarin, and histamine blockers and should be taken at separate times from these medications.FibroMalic
|
| |
Warning! Read carefully before using Fibro Malic |
|
| If pregnant or lactating, consult your physician before taking
this product. Magnesium may cause loose stools in some
individuals.
|
| |
